Human immunodeficiency virus and assisted reproduction: Reconsidering evidence, reframing ethics

Fertility and Sterility

Volumn 75, Issue 5, 2001, Pages 843-858

  Drapkin Lyerly, Anne ^a,b,c   Anderson, Jean ^b  

^a GEORGETOWN UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

AIDS; Americans with Disabilities Act; Ethics; HIV; Infertility; Reproduction; Women

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; EFAVIRENZ; HYDROXYUREA; LAMIVUDINE; SEX HORMONE BINDING GLOBULIN; ZIDOVUDINE;

ARTIFICIAL INSEMINATION; CESAREAN SECTION; DECISION MAKING; DISEASE TRANSMISSION; ETHICS; FEMALE; HEALTH CARE PERSONNEL; HEALTH HAZARD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOGONADISM; IMMUNE DEFICIENCY; INFERTILITY; LAW; LIFE EXPECTANCY; MORTALITY; OPPORTUNISTIC INFECTION; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; PROGNOSIS; PUBLIC HEALTH; REVIEW; TERATOGENICITY; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS MUTATION;

GENETICS AND REPRODUCTION; HEALTH CARE AND PUBLIC HEALTH;

ACQUIRED IMMUNODEFICIENCY SYNDROME; DISEASE TRANSMISSION, VERTICAL; ETHICS, MEDICAL; FEMALE; HIV; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; INFERTILITY; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; REPRODUCTIVE TECHNIQUES;

EID: 0035042209     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(01)01700-9     Document Type: Review

References (115)

1. U.S. HIV and AIDS cases reported through December 1999
2. Practices and opinions of health-care providers serving HIV-infected women
3. Epidemiology and natural history of HIV infection in women
4. Acute human immunodeficiency virus type 1 infection
5. Early establishment of a pool of latently infected resting CD4 T cells during primary HIV-1 infection
6. HIV-1 dynamics in vivo; virion clearance rate, infected cell life-span, and viral generation time
7. Analysis of HIV-1 in the cervicovaginal secretions and blood of pregnant and nonpregnant women
8. Race, sex, drug use, and progression of human immunodeficiency virus disease
9. Effect of gender, age, transmission category, and antiretroviral therapy on the progression of human immunodeficiency virus infection using multistate Markov models
10. Serum levels of virus burden in early stage human immunodeficiency virus type 1 disease in women
11. Sex differences in HIV-1 viral load and progression to AIDS
12. Sex differences in longitudinal human immunodeficiency virus type-1 RNA levels among seroconvertors
13. Immunopathogenic mechanisms of HIV infection
14. Guidelines for the use of antiretroviral agents in human immunodeficiency virus-infected adults and adolescents
15. Update; trends in AIDS incidence, United States, 1996
16. Decline in deaths from AIDS due to new antiretrovirals
17. Impact of combination therapy for human immunodeficiency virus infection on inpatient census
18. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
19. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant
20. Trends in perinatal transmission of HIV/AIDS in the United States
21. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand; a randomized controlled trial
22. Short courses of zidovudine and perinatal transmission of HIV
23. Intrapartum and neonatal single dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda. HIVNET 012 randomised trial
24. Maternal levels of plasma immunodeficiency virus type-1 and the risk of perinatal transmission
25. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine
26. Short-course antenatal zidovudine reduces both cervicovaginal human immunodeficiency virus type 1 levels and risk of perinatal transmission
27. Maternal syphilis and vertical transmission of human immunodeficiency virus type-1 infection
28. Association of maternal drug use during pregnancy with maternal HIV culture positivity and perinatal HIV transmission
29. Cigarette smoking and maternal-child HIV transmission
30. Choriodecidual inflammation; a potentially preventable cause of perinatal HIV-1 transmission?
31. Elective cesarean section versus vaginal delivery in prevention of vertical HIV-1 transmission; a randomised clinical trial
32. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1
33. Measuring the impact of HIV on fertility in Africa
34. Population-based study of fertility in women with HIV-1 infection in Uganda
35. Changes in systemic gonadal and adrenal steroids in asymptomatic human immunodeficiency virus-infected men; relationship with the CD4 cell counts
36. Effects of clinical stage and immunological status on semen analysis results in human immunodeficiency virus type 1-seropositive men
37. The effects of disease progression and zidovudine therapy on semen quality in human immunodeficiency virus type 1 seropositive men
38. Pelvic inflammatory disease and fertility. A cohort study of 1844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results
39. Control of sexually transmitted diseases for HIV-1 prevention; understanding the implications of the Mwanza and Rakai trials
40. Prevalence of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women
41. Lower genital tract infections among HIV-infected and high-risk uninfected women; findings of the Women's Interagency HIV Study (WIHS)
42. Sexually transmitted diseases and human immunodeficiency virus infection among women with pelvic inflammatory disease
43. Pelvic inflammatory disease and human immunodeficiency virus infection
44. Effect of human immunodeficiency virus type 1 infection upon acute salpingitis; a laparoscopic study
45. Effects of alcohol abuse on reproductive function in women
46. Medical risks for women who drink alcohol
47. Semen analysis in alcohol dependence syndrome
48. Recreational drug use and the risk of primary infertility
49. Mechanism of action of narcotics in the production of menstrual dysfunction in women
50. Semen evaluation in heroin and methadone addicts
51. Immunological markers in HIV-infected pregnant women
52. The influence of pregnancy on human immunodeficiency virus type 1 infection; antepartum and postpartum changes in human immunodeficiency virus type 1 viral load
53. The effect of pregnancy on survival in women infected with HIV; a systematic review of the literature and meta-analysis
54. The association between maternal HIV infection and perinatal outcome; a systematic review of the literature and meta-analysis
55. Antiretroviral therapy for pregnant women
56. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment
57. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women
58. Lack of tumors in infants with perinatal HIV-1 exposure and fetal/neonatal exposure to zidovudine
59. Incidence of premature birth and neonatal respiratory disease in infants of HIV-positive mothers
60. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues
61. Occupational risk of human immunodeficiency virus infection in health care workers; an overview
62. Type B hepatitis; the infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposure
63. Occupational exposure to hepatitis C virus; a dilemma
64. Italian Study Group on Occupational Risk of HIV and Other Bloodborne Infections. Risk of hepatitis C seroconversion after occupational exposures in health care workers
65. The Italian Study Group on Occupational Risk of HIV Infection. The risk of occupational human immunodeficiency virus infection in health care workers; Italian multicenter study
66. A case-control study of HIV seroconversion in health care workers after percutaneous exposure
67. Failures of zidovudine postexposure prophylaxis
68. Public Health Service guidelines for the management of health care worker exposures to HIV and recommendations for postexposure prophylaxis
69. Viral load and heterosexual transmission of human immunodeficiency virus type-1
70. Reproductive counseling for HIV-discordant couples
71. Assisted conception in HIV discordant couples; evaluation of semen processing techniques in reducing HIV viral load
72. Microscopic evidence against HIV-1 infection of germ cells or attachment to sperm
73. AIDS and reproductive decisions; having children in fear and trembling
74. Human immunodeficiency virus infections in children; public health and public policy issues
75. Infertility management in HIV positive couples; a dilemma
76. Infertility among human immunodeficiency virus-positive women; incidence and treatment dilemmas
77. Infertility among HIV-positive women; counseling HIV patients pursuing infertility investigation and treatment
78. Special considerations regarding human immunodeficiency virus and assisted reproductive technologies
79. FIGO Committee for the Study of Ethical Aspects of Human Reproduction; guidelines on the subject of AIDS and human reproduction
80. Regulating assisted reproductive technologies; an ethical framework
81. Case study; ethics consultation
82. The moral right to have children
83. Policy, ethics and reproductive choice; pregnancy and childbearing among HIV-infected women
84. State intervention, reproduction, and HIV-infected women
85. Issues related to human immunodeficiency virus transmission in schools, child care, medical settings, the home and community
86. Maternal serum alpha-fetoprotein, age, and Down syndrome risk
87. Malformation in infant of diabetic mothers occur before the seventh gestational week. Implications for treatment
88. When do health care decisions discriminate against persons with disabilities?
89. Discrimination against the infertile; the Supreme Court speaks out
90. Protecting patients from discrimination-the Americans with Disabilities Act and HIV infection
91. Disability discrimination in America; HIV/AIDS and other health conditions
92. Clinical challenge; addressing the issue of childbearing in heterosexual couples discordant for HIV